Načítá se...
Comparative studies of oxaliplatin-based platinum(iv) complexes in different in vitro and in vivo tumor models†
Using platinum(iv) prodrugs of clinically established platinum(ii) compounds is a strategy to overcome side effects and acquired resistances. We studied four oxaliplatin-derived platinum(iv) complexes with varying axial ligands in various in vitro and in vivo settings. The ability to interfere with...
Uloženo v:
| Vydáno v: | Metallomics |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6130776/ https://ncbi.nlm.nih.gov/pubmed/28205649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c6mt00226a |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|